Retinal arteriole-to-venule ratio changes and target organ disease evolution in newly diagnosed hypertensive patients at 1-year follow-up

Keith, 1974, Some different types of essential hypertension: their course and prognosis, Am J Med Sci, 268, 336, 10.1097/00000441-197412000-00004 Breslin, 1966, Prognostic importance of ophtalmologic findings in essential hypertension, JAMA, 195, 335, 10.1001/jama.1966.03100050043015 van den Born, 2005, Value of routine funduscopy in patients with hypertension: systematic review, BMJ, 331, 73, 10.1136/bmj.331.7508.73 Cuspidi, 2004, Retinal microvascular changes and target organ damage in untreated essential hypertensives, J Hypertens, 22, 2095, 10.1097/00004872-200411000-00010 Porta, 2005, Hypertensive retinopathy: there’s more than meets the eye, J. Hypertension, 23, 683, 10.1097/01.hjh.0000163131.77267.11 Wong, 2007, The eye in hypertension, Lancet, 369, 425, 10.1016/S0140-6736(07)60198-6 2013, 2013 ESH/ESC Guidelines for the management of arterial hypertension, J Hypertens, 31, 1281, 10.1097/01.hjh.0000431740.32696.cc Wong, 2004, Hypertensive retinopathy, NEJM, 351, 2310, 10.1056/NEJMra032865 Wong, 2005, Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality, Br Med Bull, 73-74, 57, 10.1093/bmb/ldh050 Masaidi, 2009, Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?, J Hypertens, 27, 1277, 10.1097/HJH.0b013e32832a4012 Grosso, 2006, Comparison between generalized retinal arteriolar narrowing and left ventricular mass in young untreated hypertensive patients, Blood Press, 15, 308, 10.1080/08037050600996792 Cuspidi, 2012, Do microvascular retinal changes improve cardiovascular risk estimation?, J Hypertens, 30, 682, 10.1097/HJH.0b013e3283516876 Cheung, 2012, Retinal microvasculature as a model to study the manifestations of hypertension, Hypertension, 60, 1094, 10.1161/HYPERTENSIONAHA.111.189142 Wong, 2004, Associations between the metabolic syndrome and retinal microvascular signs: The Atherosclerosis Risk in Communities Study, Invest Ophthalmol Vis Sci, 45, 2949, 10.1167/iovs.04-0069 Wong, 2003, Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people, Neurology, 61, 806, 10.1212/01.WNL.0000086372.05488.8D Wong, 2002, Cerebral white matter lesions, retinopathy and incident clinical stroke, JAMA, 288, 67, 10.1001/jama.288.1.67 Baker, 2007, Retinal microvascular signs, cognitive function, and dementia in older persons. The Cardiovascular Health Study, Stroke, 38, 2041, 10.1161/STROKEAHA.107.483586 Ikram, 2004, Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study, Invest Ophthalmol Vis Sci, 45, 2129, 10.1167/iovs.03-1390 Wong, 2004, Retinal arteriolar diameter and risk for hypertension, Ann Intern Med, 140, 248, 10.7326/0003-4819-140-4-200402170-00006 Smith, 2004, Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study, Hypertension, 44, 442, 10.1161/01.HYP.0000140772.40322.ec Nguyen, 2008, Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study, Diabetes, 57, 536, 10.2337/db07-1376 Wong, 2005, Retinopathy and risk of congestive heart failure, JAMA, 293, 63, 10.1001/jama.293.1.63 Edwards, 2005, Associations between retinal microvascular abnormalities and declining renal function in the elderly population: The Cardiovascular Health Study, Am J Kidney Dis, 46, 214, 10.1053/j.ajkd.2005.05.005 Wang, 2006, Retinal vascular calibre and the risk of coronary heart disease-related death, Heart, 92, 1583, 10.1136/hrt.2006.090522 Wong, 2002, Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study, JAMA, 287, 1153, 10.1001/jama.287.9.1153 McGeechan, 2009, Meta-analysis: retinal vessel caliber and risk for coronary heart disease, Ann Intern Med, 151, 404, 10.7326/0003-4819-151-6-200909150-00005 Mitchell, 2005, Retinal microvascular signs and risk of stroke and stroke mortality, Neurology, 65, 1005, 10.1212/01.wnl.0000179177.15900.ca Cooper, 2006, Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction. The Atherosclerosis Risk in Communities Study, Stroke, 37, 82, 10.1161/01.STR.0000195134.04355.e5 Coll de Tuero, 2006, Assessment of self-monitoring blood pressure in the diagnosis of isolated clinic hypertension, Blood Press, 15, 227, 10.1080/08037050600912203 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Dalfó, 1997, Electrocardiographic diagnosis of left ventricular hypertrophy (LVH). Proposal of modification of Cornell criteria, Am J Hypertens, 10, 206A, 10.1016/S0895-7061(97)89408-3 Saez, 2012, Development of an automated system to classify retinal vessels into arteries and veins, Comput Methods Programs Biomed, 108, 367, 10.1016/j.cmpb.2012.02.008 Pose-Reino, 2005, Computerized measurement of retinal blood vessel calibre: description, validation and use to determine the influence of ageing and hypertension, J Hypertens, 23, 843, 10.1097/01.hjh.0000163154.35577.8e Vázquez, 2012, The significance of the vessel registration for a reliable computation of arteriovenous ratio, ICIAR, 2, 347 Pose-Reino, 2006, Regression of alterations in retinal microcirculation following treatment for arterial hypertension, J Clin Hypertens, 8, 590, 10.1111/j.1524-6175.2006.05476.x Coll-de-Tuero, 2012, Evolution of target organ damage by different values of self-blood pressure measurement in untreated hypertensive patients, Am J Hypertens, 25, 1256 Dahlöf, 1992, Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment, Blood Press, 1, 35, 10.3109/08037059209065122 Okin, 2003, Losartan Intervention for Endpoint reduction in hypertension Study Investigations Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study, Circulation, 108, 684, 10.1161/01.CIR.0000083724.28630.C3 Ibsen, 2005, Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension Study, Hypertension, 45, 198, 10.1161/01.HYP.0000154082.72286.2a Olsen, 2005, Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) substudy, Am J Hypertens, 18, 1430, 10.1016/j.amjhyper.2005.05.030 Vernooij, 2013, Hypertensive target organ damage and the risk for vascular events and all-causemortality in patients with vascular disease, J Hypertens, 31, 492, 10.1097/HJH.0b013e32835cd3cd